Donald V. Unverferth

Factors influencing the one-year mortality of dilated cardiomyopathy

Donald V. Unverferth, Raymond D. Magorien, Melvin L. Moeschberger et al. · The American Journal of Cardiology · 1984 · 551 citations

One-year Mortality, Cardiomyopathy, Heart Failure +4

Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.

C V Leier, Patricia Huss, Raymond D. Magorien et al. · Circulation · 1983 · 294 citations

Hypertension, Heart Failure, Cardiovascular Function +21

Tolerance to dobutamine after a 72 hour continuous infusion

Donald V. Unverferth, Marvin F. Blanford, Robert E. Kates et al. · The American Journal of Medicine · 1980 · 243 citations

Hour Continuous Infusion, Pharmacotherapy, Anesthesia +3

Effect of exercise training on antioxidant enzymes and cardiotoxicity of doxorubicin

M. M. Kanter, Robert L. Hamlin, Donald V. Unverferth et al. · Journal of Applied Physiology · 1985 · 202 citations

Physical Activity, Lipid Peroxidation, Antioxidant Enzymes +19

Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy

Donald V. Unverferth, Peter B. Baker, Steven Swift et al. · The American Journal of Cardiology · 1986 · 165 citations

Cardiac Muscle, Cardiomyopathy, Heart Failure +7